The latest updates from the RTW team

News & events

Portfolio company update: Third Harmonic Bio IPO

JiXing: Disruptive science, driven by heart

JiXing: Disruptive science, driven by heart

Post-launch, pre-cliff: The R&D congress ignores

Post-launch, pre-cliff: The R&D congress ignores

Rocket: Seeking gene therapy cures

Rocket: Seeking gene therapy cures

Connect with us

Latest news

RTW Charitable Foundation Supports Medical Relief Efforts in Turkey and Syria with $50,000 Emergency Response Grant to the Syrian American Medical Society (SAMS) Foundation

RTW Charitable Foundation Supports Medical Relief Efforts in Turkey and Syria with $50,000 Emergency Response Grant to the Syrian American Medical Society (SAMS) Foundation

New investment in Apogee Therapeutics

Portfolio company update: Third Harmonic Bio IPO

Portfolio company update: Third Harmonic Bio IPO

Latest insights

JiXing: Disruptive science, driven by heart

JiXing: Disruptive science, driven by heart

Post-launch, pre-cliff: The R&D congress ignores

Post-launch, pre-cliff: The R&D congress ignores

Rocket: Seeking gene therapy cures

Rocket: Seeking gene therapy cures

Updates from RTW
Sign up for news & insights

In the news

CNBC

CNBC's The Halftime Report with Scott Wapner Featuring Rod Wong on Biotech Market in 2023 and More

Read article
The Hedge Fund Journal

RTW’s Stephanie Sirota featured in the Hedge Fund Journal's 50 leading women in hedge funds

Read article
Beckers Hospital Review

Stephanie Sirota discusses the biotech innovation market

Read article
BIOS Community

Rod Wong featured guest on the BIOS Ventures podcast with Alix Ventures' Chris Ghadban

Read article